With that in mind, let's consider two stocks down 17% and 36%, respectively, this year that are worth investing in right now: ...

If found to be lacking adequate compliance systems, Moderna could ultimately be suspended or expelled from the Association of ...

The Cleburne Railroaders hosted their first taste of baseball at La Moderna Field with exhibition games between the Charros ...

Novavax announced that it's COVID-19 vaccine could get full approval from the U.S. Food and Drug Administration soon.The ...

Jenny Strasburg is a reporter in London, where she writes for The Wall Street Journal about oil and gas, climate, the ...

James Willhite was an editor with The Wall Street Journal's money & investing team based in London.

Nearly a year and a half after Covid vaccines became available to adults in the U.S., the FDA has authorized two vaccines for ...

In the closing of the recent trading day, Cleveland-Cliffs (CLF) stood at $7.91, denoting no change from the preceding trading day.

The latest trading day saw Moderna (MRNA) settling at $27.19, representing a -0.75% change from its previous close.

(Reuters) -Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after ...

The technology is genuinely useful for scientific discovery, but its applications are less dramatic than you might think.

FRIDAY, April 25, 2025 (HealthDay News) -- On Tuesday, the U.S. Department of Health and Human Services announced that the government will invest $176 million in Moderna to expedite the creation of a ...